Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate whether 2 different tablet compositions are similar regarding absorption (uptake) in the body. One composition was used in the clinical development program and the other is intended for the market


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02894515
Study type Interventional
Source H. Lundbeck A/S
Contact
Status Withdrawn
Phase Phase 1
Start date September 2016
Completion date September 2016

See also
  Status Clinical Trial Phase
Completed NCT03705533 - Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State Phase 1
Completed NCT03646331 - Bioequivalence of Imeglimin Tablet Formulations Phase 1
Completed NCT03702894 - Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions Phase 1
Completed NCT03018015 - Ibuprofen Bioavailability Trial With Oral Single Dose Administration. Phase 1
Completed NCT02206295 - Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg Phase 1
Completed NCT01331993 - A Bioequivalence Study to Compare VIMOVO Manufactured at AstraZenca AB to VIMOVO Manufactured by Patheon Pharmaceuticals and Marketed Enteric-coated Naproxen Formulation Phase 1
Completed NCT01260805 - A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers. Phase 1
Recruiting NCT03340753 - Bioavailability of KBP-5074 Tablet vs Capsule Formulations Phase 1
Completed NCT03273192 - A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects Phase 1
Not yet recruiting NCT03749733 - Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate Phase 1
Completed NCT03337126 - Bioavailability of ATI-1501 With Taste Test Sub Study Phase 1
Recruiting NCT03614715 - Pharmacokinetics and Pharmacodynamics of CinnoVex (Interferon Beta-1a) Compared to Avonex (Interferon Beta-1a) Phase 1
Completed NCT01638143 - Bio-equivalence Study N/A
Completed NCT03751202 - A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers Phase 1
Active, not recruiting NCT03420534 - Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone Tablets Phase 1
Completed NCT02341274 - Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers Phase 1
Recruiting NCT03951051 - The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions. Phase 1
Recruiting NCT03918551 - Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions Phase 1
Completed NCT03573050 - Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase Phase 1
Active, not recruiting NCT03915340 - Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions Phase 1